Canada -
français -
Health Canada
auro-candesartan hct comprimé
auro pharma inc - candésartan cilexétil; hydrochlorothiazide - comprimé - 16mg; 12.5mg - candésartan cilexétil 16mg; hydrochlorothiazide 12.5mg - angiotensin ii receptor antagonists
Canada -
français -
Health Canada
auro-candesartan hct comprimé
auro pharma inc - candésartan cilexétil; hydrochlorothiazide - comprimé - 32mg; 12.5mg - candésartan cilexétil 32mg; hydrochlorothiazide 12.5mg - angiotensin ii receptor antagonists
Canada -
français -
Health Canada
auro-candesartan hct comprimé
auro pharma inc - candésartan cilexétil; hydrochlorothiazide - comprimé - 32mg; 25mg - candésartan cilexétil 32mg; hydrochlorothiazide 25mg - angiotensin ii receptor antagonists
Canada -
français -
Health Canada
avandamet comprimé
glaxosmithkline inc - rosiglitazone (maléate de rosiglitazone); chlorhydrate de metformine - comprimé - 1mg; 500mg - rosiglitazone (maléate de rosiglitazone) 1mg; chlorhydrate de metformine 500mg - biguanides
Canada -
français -
Health Canada
avandamet comprimé
glaxosmithkline inc - rosiglitazone (maléate de rosiglitazone); chlorhydrate de metformine - comprimé - 2mg; 500mg - rosiglitazone (maléate de rosiglitazone) 2mg; chlorhydrate de metformine 500mg - biguanides
Canada -
français -
Health Canada
avandamet comprimé
glaxosmithkline inc - rosiglitazone (maléate de rosiglitazone); chlorhydrate de metformine - comprimé - 4mg; 500mg - rosiglitazone (maléate de rosiglitazone) 4mg; chlorhydrate de metformine 500mg - biguanides
Canada -
français -
Health Canada
avandamet comprimé
glaxosmithkline inc - rosiglitazone (maléate de rosiglitazone); chlorhydrate de metformine - comprimé - 2.00mg; 1000mg - rosiglitazone (maléate de rosiglitazone) 2.00mg; chlorhydrate de metformine 1000mg - biguanides
Canada -
français -
Health Canada
avandamet comprimé
glaxosmithkline inc - rosiglitazone (maléate de rosiglitazone); chlorhydrate de metformine - comprimé - 4.00mg; 1000mg - rosiglitazone (maléate de rosiglitazone) 4.00mg; chlorhydrate de metformine 1000mg - biguanides
Union européenne -
français -
EMA (European Medicines Agency)
purevax rc
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains) - immunologicals pour felidae, - chats - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs. onsets of immunity isone week after primary vaccination course. the duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.
Union européenne -
français -
EMA (European Medicines Agency)
purevax rcch
merial - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain) - immunologicals pour felidae, - chats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs and excretion;against chlamydophila felis infection to reduce clinical signs. des immunités ont été démontrées 1 semaine après la primovaccination pour les composants rhinotrachéite, calicivirus et chlamydophila felis. la durée de l'immunité est de 1 an après la dernière (ré) vaccination.